MA26974A1 - Benzimidazole et derives de pyridylimidazole comme ligands pour les recepteurs de gaba - Google Patents

Benzimidazole et derives de pyridylimidazole comme ligands pour les recepteurs de gaba

Info

Publication number: MA26974A1
Authority: MA; Morocco
Prior art keywords: benzimidazole; ligands; gaba receptors; pyridylimidazole derivatives; pyridylimidazole
Prior art date: 2000-12-21

Application number

MA27199A

Other languages

English (en)

Inventor

Li Guiying

M Peterson John

Albaugh Pamela

Currie Kevin

Cai Guolin

M Gustavson Linda

Lee Kyungae

Hutchison Alan

Singh Vinod

D Maynard George

Yuan Jun

Xie Linghong

Ghosh Manuka

Liu Nian

P Luke George

Mitchell Scott

Patrick Allen Martin

Liras Spiros

Original Assignee

Pfizer

Neurogen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-21

Filing date

2003-06-17

Publication date

2004-12-20

2003-06-17 Application filed by Pfizer, Neurogen Corp filed Critical Pfizer

2004-12-20 Publication of MA26974A1 publication Critical patent/MA26974A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA27199A 2000-12-21 2003-06-17 Benzimidazole et derives de pyridylimidazole comme ligands pour les recepteurs de gaba MA26974A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US25749200P	2000-12-21	2000-12-21

Publications (1)

Publication Number	Publication Date
MA26974A1 true MA26974A1 (fr)	2004-12-20

Family

ID=22976520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27199A MA26974A1 (fr)	2000-12-21	2003-06-17	Benzimidazole et derives de pyridylimidazole comme ligands pour les recepteurs de gaba

Country Status (40)

Country	Link
US (4)	US6916819B2 (fr)
EP (1)	EP1368342B3 (fr)
JP (1)	JP2004536782A (fr)
KR (1)	KR100854174B1 (fr)
CN (1)	CN1553909A (fr)
AP (1)	AP1503A (fr)
AR (1)	AR035774A1 (fr)
AT (1)	ATE304008T1 (fr)
AU (2)	AU2002232768B2 (fr)
BG (1)	BG107899A (fr)
BR (1)	BR0116385A (fr)
CA (1)	CA2431592A1 (fr)
CO (1)	CO5390086A1 (fr)
CZ (1)	CZ20031676A3 (fr)
DE (1)	DE60113302T2 (fr)
EA (1)	EA007157B1 (fr)
EC (1)	ECSP034656A (fr)
EE (1)	EE05108B1 (fr)
EG (1)	EG24590A (fr)
ES (1)	ES2256325T3 (fr)
HR (1)	HRP20030483A9 (fr)
HU (1)	HUP0303849A3 (fr)
IL (1)	IL156294A0 (fr)
IS (1)	IS6855A (fr)
MA (1)	MA26974A1 (fr)
MX (1)	MXPA03005493A (fr)
MY (1)	MY141733A (fr)
NO (1)	NO326558B1 (fr)
NZ (1)	NZ526330A (fr)
OA (1)	OA12539A (fr)
PA (1)	PA8535601A1 (fr)
PE (1)	PE20020720A1 (fr)
PL (1)	PL366243A1 (fr)
SK (1)	SK7672003A3 (fr)
TW (1)	TWI304402B (fr)
UA (1)	UA75902C2 (fr)
UY (1)	UY27095A1 (fr)
WO (1)	WO2002050062A2 (fr)
YU (1)	YU51703A (fr)
ZA (1)	ZA200304544B (fr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI248936B (en) *	2001-03-21	2006-02-11	Merck Sharp & Dohme	Imidazo-pyrimidine derivatives as ligands for GABA receptors
IL159811A0 (en) *	2001-07-13	2004-06-20	Neurogen Corp	Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
WO2003060475A2 (fr)	2002-01-10	2003-07-24	Neurogen Corporation	Ligands recepteurs de l'hormone de concentration de la melanine: 2-(4-benzyl-piperazine-1-ylmethyl)- substitue et analogues de 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole
EP1465888A2 (fr)	2002-01-10	2004-10-13	Neurogen Corporation	Ligands recepteurs de l'hormone de concentration de la melanine: analogues de benzoimidazole substitue
AU2003245259A1 (en) *	2002-05-02	2003-11-17	Neurogen Corporation	Substituted imidazole derivatives: gabaa receptor ligands
AU2003301864A1 (en) *	2002-05-08	2004-06-07	Neurogen Corporation	Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands
ATE333455T1 (de) *	2002-05-17	2006-08-15	Neurogen Corp	Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden
US20040063938A1 (en) *	2002-09-30	2004-04-01	Pfizer Inc	Process for preparing haloalkyl pyrimidines
CN100579579C (zh) *	2002-10-01	2010-01-13	诺华疫苗和诊断公司	抗癌及抗感染性疾病组合物及其使用方法
WO2004041808A1 (fr) *	2002-11-08	2004-05-21	Neurogen Corporation	Derives de 4-imidazol-1-ylmethyl-pyrimidine en tant que ligands de recepteurs gabaa
WO2004054515A2 (fr) *	2002-12-13	2004-07-01	Smithkline Beecham Corporation	Mimetiques de la thrombopoietine
US7169801B2 (en) *	2003-03-17	2007-01-30	Takeda San Diego, Inc.	Histone deacetylase inhibitors
SE0301699D0 (sv) *	2003-06-10	2003-06-10	Astrazeneca Ab	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
EP1880998A1 (fr) *	2003-07-25	2008-01-23	Neurogen Corporation	Imidazopyrimidines et triazolopyrimidines comme ligands du récepteur de benzodiazepines.
PT1648899E (pt) *	2003-07-25	2007-03-30	Neurogen Corp	Imidazo-pirimidinas e triazolo-pirimidinas: ligandos do receptor de benzodiazepina
ZA200600037B (en) *	2003-07-25	2007-04-25	Neurogen Corp	Imidazo-pyrimidines and triazolo-pyrimidines: Benzodiazepine receptor ligands
DE602004027932D1 (de)	2003-09-22	2010-08-12	S Bio Pte Ltd	Benzimidazolderivate: herstellung und pharmazeutische anwendungen
HUP0304101A3 (en) *	2003-12-22	2008-10-28	Sanofi Aventis	Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
WO2005121132A1 (fr) *	2004-06-11	2005-12-22	Shionogi & Co., Ltd.	Composé hétérocyclique fondu ayant un effet anti-vhc
US7534796B2 (en)	2005-02-18	2009-05-19	Wyeth	Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en)	2005-02-18	2009-05-26	Wyeth	4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en)	2005-02-18	2009-09-01	Wyeth	7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en)	2005-05-18	2009-05-12	Wyeth	Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en)	2005-05-26	2009-09-01	Wyeth	Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
BRPI0617306A2 (pt) *	2005-10-11	2011-07-19	Hoffmann La Roche	derivados de isoxazol
CN101346372B (zh)	2005-12-23	2011-09-28	弗·哈夫曼-拉罗切有限公司	芳基-异唑-4-基-二唑衍生物
KR101121372B1 (ko)	2005-12-27	2012-04-12	에프. 호프만-라 로슈 아게	아릴-이속사졸-4-일-이미다졸 유도체
BRPI0706560A2 (pt)	2006-01-17	2011-03-29	Hoffmann La Roche	derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
EP2029559B1 (fr)	2006-05-31	2009-08-05	F. Hoffmann-Roche AG	Dérivés d'aryl-4-éthynyl-isoxazole
TW200808772A (en) *	2006-06-13	2008-02-16	Astrazeneca Ab	Therapeutic compounds
WO2008016123A1 (fr) *	2006-08-03	2008-02-07	Takeda Pharmaceutical Company Limited	INHIBITEUR DE LA GSK-3β
WO2008051533A2 (fr) *	2006-10-25	2008-05-02	Takeda Pharmaceutical Company Limited	Composés de benzimidazole
ATE519760T1 (de)	2007-06-22	2011-08-15	Hoffmann La Roche	Isoxazolimidazolderivate
TW200911803A (en) *	2007-07-16	2009-03-16	Organon Nv	6-phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
WO2009023126A2 (fr) *	2007-08-10	2009-02-19	Cortex Pharmaceuticals, Inc.	Amides bicycles permettant d'améliorer les réponses synaptiques glutamatériques
WO2009071464A1 (fr)	2007-12-04	2009-06-11	F. Hoffmann-La Roche Ag	Dérivés d'isoxazolo-pyrazine
US7943619B2 (en)	2007-12-04	2011-05-17	Hoffmann-La Roche Inc.	Isoxazolo-pyridazine derivatives
US7902201B2 (en)	2007-12-04	2011-03-08	Hoffmann-La Roche Inc.	Isoxazolo-pyrazine derivatives
TW201033201A (en)	2009-02-19	2010-09-16	Hoffmann La Roche	Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en)	2009-02-25	2013-03-05	Hoffmann-La Roche Inc.	Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en)	2009-04-02	2012-07-17	Hoffmann-La Roche Inc.	Substituted isoxazoles
US8227461B2 (en)	2009-04-30	2012-07-24	Hoffmann-La Roche Inc.	Isoxazoles
AU2010244553A1 (en)	2009-05-05	2011-12-01	F. Hoffmann-La Roche Ag	Isoxazole-pyridine derivatives
JP6026273B2 (ja)	2009-05-05	2016-11-16	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	イソオキサゾール−ピリダジン誘導体
MX2011011273A (es)	2009-05-05	2011-11-04	Hoffmann La Roche	Derivados de isoxazol-pirazol.
CN102414208B (zh)	2009-05-05	2014-11-05	霍夫曼-拉罗奇有限公司	作为用于认知性障碍的治疗中的gaba a受体逆激动剂的异*唑-噻唑衍生物
EP2427457B1 (fr)	2009-05-07	2013-07-17	F.Hoffmann-La Roche Ag	Dérivés d'isoxazole-pyridine en tant que modulateurs de gaba
CN103209981B (zh) *	2010-09-10	2016-12-28	盐野义制药株式会社	具有ampk活化作用的杂环稠合咪唑衍生物
US20130196990A1 (en)	2010-10-06	2013-08-01	Junya Qu	Benzimidazole Derivatives As PI3 Kinase Inhibitors
NO3034079T3 (fr)	2010-11-15	2018-06-09
BR112013021236B1 (pt) *	2011-02-25	2021-05-25	Merck Sharp & Dohme Corp	composto derivado de benzimidazol, e, composição
ES2786298T3 (es)	2011-03-03	2020-10-09	Zalicus Pharmaceuticals Ltd	Inhibidores de benzimidazol del canal de sodio
CN102653531B (zh) *	2011-03-04	2014-08-13	上海爱普植物科技有限公司	一种马索亚内酯的合成方法
AU2012293611B2 (en) *	2011-08-11	2017-02-09	Bayer Cropscience Ag	1,2,4-triazolyl-substituted keto-enols
US8785435B2 (en)	2011-10-20	2014-07-22	Hoffmann-La Roche Inc.	Solid forms
GB201119538D0 (en) *	2011-11-10	2011-12-21	Viral Ltd	Pharmaceutical compounds
HK1201270A1 (en)	2012-01-11	2015-08-28	Bayer Intellectual Property Gmbh	Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
US9296725B2 (en)	2012-05-24	2016-03-29	Cellzome Limited	Heterocyclyl pyrimidine analogues as TYK2 inhibitors
JP6230344B2 (ja) *	2013-09-06	2017-11-15	株式会社東芝	蒸気タービンプラント
WO2015052173A1 (fr)	2013-10-10	2015-04-16	Basf Se	Composés tétrazole et triazole et leur utilisation en tant qu'herbicides
WO2015052178A1 (fr)	2013-10-10	2015-04-16	Basf Se	Composés de 1,2,5-oxadiazole et leur utilisation en tant qu'herbicides
NZ722077A (en)	2013-12-20	2021-12-24	Agenebio Inc	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2015115673A1 (fr) *	2014-01-31	2015-08-06	Ono Pharmaceutical Co., Ltd.	Composés d'imidazole condensés
AR099287A1 (es) *	2014-02-17	2016-07-13	Bayer Cropscience Ag	Derivados de heterociclos bicíclicos condensados sustituidos con 2-(het)arilo como agentes para combatir parásitos
JP6785217B2 (ja) *	2014-07-31	2020-11-18	インスティチュートパスツールコリア	２−アミノ−ベンゾイミダゾール誘導体ならびにこれらの５−リポキシゲナーゼおよび／またはプロスタグランジンｅシンターゼ阻害剤としての使用
EP3954685B1 (fr)	2014-12-29	2025-08-27	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Inhibiteurs à petite molécule de lactate déshydrogénase et leurs procédés d'utilisation
UY36547A (es)	2015-02-05	2016-06-01	Bayer Cropscience Ag	Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
UY36548A (es)	2015-02-05	2016-06-01	Bayer Cropscience Ag	Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
CN107810188B (zh)	2015-04-08	2020-09-22	拜耳作物科学股份公司	作为害虫防治剂和中间体产物的稠合双环杂环衍生物
CN113264939A (zh)	2015-06-19	2021-08-17	艾吉因生物股份有限公司	用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
CN107922396B (zh)	2015-07-20	2022-08-05	建新公司	集落刺激因子-1受体(csf-1r)抑制剂
CN118955472A (zh)	2015-08-07	2024-11-15	拜耳作物科学股份公司	作为农药的2-(杂)芳基取代的稠合杂环衍生物
RU2018119344A (ru)	2015-10-26	2019-11-28	Байер Кропсайенс Акциенгезельшафт	Конденсированные бициклические гетероциклические производные в качестве средства для борьбы с вредителями
WO2017093180A1 (fr)	2015-12-01	2017-06-08	Bayer Cropscience Aktiengesellschaft	Dérivés hétérocycles bicycliques condensés utilisés en tant que produits de lutte antiparasitaire
WO2017144341A1 (fr)	2016-02-23	2017-08-31	Bayer Cropscience Aktiengesellschaft	Dérivés hétérocycliques bicycliques condensés utilisés en tant que produits de lutte antiparasitaire
WO2017157332A1 (fr) *	2016-03-18	2017-09-21	江苏恒瑞医药股份有限公司	Dérivé amide aromatique, procédé de préparation de ce dernier, et applications pharmaceutiques de ce dernier
WO2017174414A1 (fr)	2016-04-05	2017-10-12	Bayer Cropscience Aktiengesellschaft	Dérivés de naphtaline utilisés comme agents de lutte contre les nuisibles
AR108257A1 (es)	2016-05-02	2018-08-01	Mei Pharma Inc	Formas polimórficas de 3-[2-butil-1-(2-dietilamino-etil)-1h-bencimidazol-5-il]-n-hidroxi-acrilamida y usos de las mismas
EP3241830A1 (fr)	2016-05-04	2017-11-08	Bayer CropScience Aktiengesellschaft	Derivés de bicycles condensés hétérocycliques utilisés comme pesticides
CN109689662B (zh)	2016-07-19	2022-03-15	拜耳作物科学股份公司	作为害虫防治剂的稠合双环杂环衍生物
BR112019003158B1 (pt)	2016-08-15	2022-10-25	Bayer Cropscience Aktiengesellschaft	Derivados de heterociclo bicíclico condensado, seu uso, formulação agroquímica, e método para controlar pragas animais
KR102420235B1 (ko)	2016-08-16	2022-07-12	바이엘 크롭사이언스 악티엔게젤샤프트	3H-이미다졸[4,5-c]피리딘 유도체와 유기금속 아연-아민 염기의 반응에 의한 2-(3,6-디할로피리딘-2-일)-3H-이미다졸[4,5-c]피리딘 유도체 및 관련 화합물의 제조 방법
CN109963860A (zh)	2016-09-19	2019-07-02	拜耳作物科学股份公司	吡唑并[1,5-a]吡啶衍生物及其作为农药的用途
WO2018065292A1 (fr)	2016-10-06	2018-04-12	Bayer Cropscience Aktiengesellschaft	Dérivés d'hétérocyclène bicycliques condensés substitués par 2 (het)-aryle utilisés comme pesticides pour lutter contre les bioagresseurs
US10961248B2 (en)	2016-12-01	2021-03-30	Syngenta Participations Ag	Pesticidally active heterocyclic derivatives with sulfur containing substituents
US11505555B2 (en)	2016-12-19	2022-11-22	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en)	2016-12-19	2018-06-21	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2018138050A1 (fr)	2017-01-26	2018-08-02	Bayer Aktiengesellschaft	Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides
TW201833107A (zh)	2017-02-06	2018-09-16	德商拜耳廠股份有限公司	作為殺蟲劑之經２－（雜）芳基取代的稠合雜環衍生物
EP3615540B1 (fr)	2017-04-24	2022-04-27	Bayer Aktiengesellschaft	Dérivés d'hétérocyclène bicycliques condensés en tant que pesticides
USRE50663E1 (en)	2017-10-04	2025-11-18	Bayer Aktiengesellschaft	Heterocycle derivatives as pesticides
EP3305786A3 (fr)	2018-01-22	2018-07-25	Bayer CropScience Aktiengesellschaft	Dérivés d'hétérocyclène bicycliques condensés en tant que pesticides
JP2021514949A (ja)	2018-02-21	2021-06-17	バイエル・アクチエンゲゼルシヤフト	有害生物防除剤としての縮合二環式ヘテロ環誘導体
AU2019254499A1 (en)	2018-04-20	2020-12-03	Bayer Aktiengesellschaft	Heterocyclene derivatives as pest control agents
US11414425B2 (en)	2018-06-19	2022-08-16	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN112119065B (zh) *	2018-07-13	2024-01-23	四川科伦博泰生物医药股份有限公司	苯并二氮杂环类化合物、其制备方法及用途
EP3636645A1 (fr)	2018-10-11	2020-04-15	Bayer Aktiengesellschaft	Procédé de production de préparation de dérivés de pyridine substitués par du soufre
KR20210133240A (ko)	2019-02-26	2021-11-05	바이엘 악티엔게젤샤프트	살충제로서의 융합된 비시클릭 헤테로사이클 유도체
EP3931192B1 (fr)	2019-02-26	2024-03-20	Bayer Aktiengesellschaft	Dérivés d'hétérocyclène bicycliques condensés en tant que pesticides
AR119140A1 (es)	2019-06-13	2021-11-24	Pi Industries Ltd	Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas
CN110407744A (zh) *	2019-08-13	2019-11-05	上海毕得医药科技有限公司	一种1-(4-氨基吡啶-2-基)乙酮的合成方法
CN111072681B (zh) *	2019-12-11	2020-11-06	郑州大学	一种靶向细胞膜表面gaba受体荧光探针及其制备方法和应用
EP4267573A1 (fr)	2020-12-23	2023-11-01	Genzyme Corporation	Inhibiteurs deutérés du récepteur du facteur 1 de stimulation des colonies (csp-1r)
US20240132513A1 (en)	2022-08-19	2024-04-25	Agenebio, Inc.	Benzazepine derivatives, compositions, and methods for treating cognitive impairment
CN115490646A (zh) *	2022-10-10	2022-12-20	安徽昊帆生物有限公司	3-硝基-1，2，4-三氮唑的制备方法
CN117486846B (zh) *	2023-10-31	2025-10-03	陕西科技大学	一种卡瓦内酯类化合物的全合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3150486A1 (de) *	1981-12-19	1983-08-25	Merck Patent Gmbh, 6100 Darmstadt	Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
WO1996033194A1 (fr)	1995-04-21	1996-10-24	Neurosearch A/S	Composes de benzimidazole et leur utilisation en tant que modulateurs du complexe de recepteurs gaba¿a?
GB9702524D0 (en) *	1997-02-07	1997-03-26	Merck Sharp & Dohme	Therapeutic agents
CA2282761A1 (fr)	1997-03-04	1998-09-11	Medtronic, Inc.	Ruban mince de fermeture d'une bioprothese pour agrafeuse chirurgicale et son procede de fixation
CA2369553A1 (fr)	1999-04-02	2000-10-12	Raymond F. Horvath	N-benzimidazolylmethyl- et n-indolylmethyl-benzamides et leur application comme modulateurs de corticoliberine
ES2226812T3 (es) *	1999-04-02	2005-04-01	Neurogen Corporation	Derivados de aminoalquilimidazol condensados con arilo y heteroarilo:moduladores selesctivos de los preseptores gabaa.
CA2369549A1 (fr)	1999-04-02	2000-10-12	Robert W. Desimone	Derives d'aminoalkyle-imidazole condenses aryles et heteroaryles et leur utilisation comme antidiabetiques
JP2002541145A (ja)	1999-04-02	2002-12-03	ニューロゲンコーポレイション	アリールおよびヘテロアリール縮合アミノアルキル−イミダゾール誘導体：ブラジキニンｂ２受容体選択性モジュレータ
US6512062B1 (en) *	1999-04-08	2003-01-28	The University Of North Carolina At Chapel Hill	Polymerization of non-fluorinated monomers in carbon dioxide
AU777961B2 (en)	1999-06-22	2004-11-04	Neurosearch A/S	Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
GB9921150D0 (en) *	1999-09-07	1999-11-10	Merck Sharp & Dohme	Therapeutic agents
WO2002049993A2 (fr)	2000-09-29	2002-06-27	Neurogen Corporation	Petites molecules modulatrices des recepteurs c5a a haute affinite
US20030055037A1 (en)	2000-10-06	2003-03-20	Delombaert Stephane	Benzimidazole and indole derivatives as CRF receptor modulators
US7030150B2 (en)	2001-05-11	2006-04-18	Trimeris, Inc.	Benzimidazole compounds and antiviral uses thereof

2001
- 2001-12-20 PA PA20018535601A patent/PA8535601A1/es unknown
- 2001-12-21 WO PCT/US2001/050038 patent/WO2002050062A2/fr not_active Ceased
- 2001-12-21 AP APAP/P/2003/002818A patent/AP1503A/en active
- 2001-12-21 DE DE60113302T patent/DE60113302T2/de not_active Expired - Lifetime
- 2001-12-21 HU HU0303849A patent/HUP0303849A3/hu unknown
- 2001-12-21 UY UY27095A patent/UY27095A1/es not_active Application Discontinuation
- 2001-12-21 PL PL01366243A patent/PL366243A1/xx not_active Application Discontinuation
- 2001-12-21 IL IL15629401A patent/IL156294A0/xx unknown
- 2001-12-21 TW TW090131848A patent/TWI304402B/zh not_active IP Right Cessation
- 2001-12-21 AU AU2002232768A patent/AU2002232768B2/en not_active Ceased
- 2001-12-21 PE PE2001001296A patent/PE20020720A1/es not_active Application Discontinuation
- 2001-12-21 AR ARP010105998A patent/AR035774A1/es unknown
- 2001-12-21 KR KR1020037008480A patent/KR100854174B1/ko not_active Expired - Fee Related
- 2001-12-21 MX MXPA03005493A patent/MXPA03005493A/es active IP Right Grant
- 2001-12-21 EA EA200300713A patent/EA007157B1/ru not_active IP Right Cessation
- 2001-12-21 ES ES01992307T patent/ES2256325T3/es not_active Expired - Lifetime
- 2001-12-21 SK SK767-2003A patent/SK7672003A3/sk unknown
- 2001-12-21 CO CO01109589A patent/CO5390086A1/es not_active Application Discontinuation
- 2001-12-21 OA OA1200300157A patent/OA12539A/en unknown
- 2001-12-21 CA CA002431592A patent/CA2431592A1/fr not_active Abandoned
- 2001-12-21 UA UA2003065755A patent/UA75902C2/uk unknown
- 2001-12-21 JP JP2002551558A patent/JP2004536782A/ja active Pending
- 2001-12-21 AU AU3276802A patent/AU3276802A/xx active Pending
- 2001-12-21 BR BR0116385-0A patent/BR0116385A/pt not_active IP Right Cessation
- 2001-12-21 NZ NZ526330A patent/NZ526330A/en active IP Right Revival
- 2001-12-21 EE EEP200300304A patent/EE05108B1/xx not_active IP Right Cessation
- 2001-12-21 CZ CZ20031676A patent/CZ20031676A3/cs unknown
- 2001-12-21 AT AT01992307T patent/ATE304008T1/de not_active IP Right Cessation
- 2001-12-21 CN CNA018223869A patent/CN1553909A/zh active Pending
- 2001-12-21 EP EP01992307A patent/EP1368342B3/fr not_active Expired - Lifetime
- 2001-12-21 HR HR20030483A patent/HRP20030483A9/xx not_active Application Discontinuation
- 2001-12-21 US US10/038,069 patent/US6916819B2/en not_active Expired - Fee Related
- 2001-12-21 YU YU51703A patent/YU51703A/sh unknown
- 2001-12-21 MY MYPI20015821A patent/MY141733A/en unknown
- 2001-12-22 EG EG20011360A patent/EG24590A/xx active
2003
- 2003-06-11 BG BG107899A patent/BG107899A/bg unknown
- 2003-06-11 ZA ZA2003/04544A patent/ZA200304544B/en unknown
- 2003-06-16 EC EC2003004656A patent/ECSP034656A/es unknown
- 2003-06-17 MA MA27199A patent/MA26974A1/fr unknown
- 2003-06-20 IS IS6855A patent/IS6855A/is unknown
- 2003-06-20 NO NO20032834A patent/NO326558B1/no not_active IP Right Cessation
2005
- 2005-07-12 US US11/179,458 patent/US7300945B2/en not_active Expired - Fee Related
2007
- 2007-11-19 US US11/942,480 patent/US7642267B2/en not_active Expired - Fee Related
2010
- 2010-01-05 US US12/652,435 patent/US20100267698A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HRP20030483A2 (en)	2005-04-30
AU3276802A (en)	2002-07-01
AR035774A1 (es)	2004-07-14
AP1503A (en)	2005-12-24
CA2431592A1 (fr)	2002-06-27
MXPA03005493A (es)	2004-04-20
TWI304402B (en)	2008-12-21
WO2002050062A3 (fr)	2003-01-16
YU51703A (sh)	2006-05-25
SK7672003A3 (en)	2004-07-07
NO326558B1 (no)	2009-01-12
UY27095A1 (es)	2002-07-31
AU2002232768B2 (en)	2007-09-06
BG107899A (bg)	2004-08-31
US20100267698A1 (en)	2010-10-21
ES2256325T3 (es)	2006-07-16
US20030069257A1 (en)	2003-04-10
US20060025425A1 (en)	2006-02-02
CO5390086A1 (es)	2004-04-30
PE20020720A1 (es)	2002-08-12
KR100854174B1 (ko)	2008-08-26
PA8535601A1 (es)	2002-11-28
EE200300304A (et)	2003-12-15
EA200300713A1 (ru)	2004-02-26
EA007157B1 (ru)	2006-08-25
EP1368342B3 (fr)	2010-12-01
US7642267B2 (en)	2010-01-05
HRP20030483A9 (en)	2007-11-30
ATE304008T1 (de)	2005-09-15
BR0116385A (pt)	2005-12-13
EE05108B1 (et)	2008-12-15
ZA200304544B (en)	2005-05-25
CZ20031676A3 (en)	2004-03-17
CN1553909A (zh)	2004-12-08
EP1368342B1 (fr)	2005-09-07
AP2003002818A0 (en)	2003-06-30
IS6855A (is)	2003-06-20
KR20030071789A (ko)	2003-09-06
US20080227793A1 (en)	2008-09-18
EP1368342A2 (fr)	2003-12-10
DE60113302D1 (de)	2005-10-13
IL156294A0 (en)	2004-01-04
HUP0303849A2 (hu)	2004-03-01
NO20032834L (no)	2003-08-08
OA12539A (en)	2006-06-05
DE60113302T2 (de)	2006-06-29
HUP0303849A3 (en)	2009-08-28
NZ526330A (en)	2006-09-29
JP2004536782A (ja)	2004-12-09
MY141733A (en)	2010-06-15
US7300945B2 (en)	2007-11-27
NO20032834D0 (no)	2003-06-20
PL366243A1 (en)	2005-01-24
ECSP034656A (es)	2003-10-28
EG24590A (en)	2009-12-07
US6916819B2 (en)	2005-07-12
UA75902C2 (en)	2006-06-15
WO2002050062A2 (fr)	2002-06-27

Publication	Publication Date	Title
MA26974A1 (fr)	2004-12-20	Benzimidazole et derives de pyridylimidazole comme ligands pour les recepteurs de gaba
AU2002232768A1 (en)	2002-09-05	Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
DZ3327A1 (fr)	2001-06-07	Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs.
DOP2001000220A (es)	2002-05-15	Derivados de imidazol
MA27230A1 (fr)	2005-02-01	Derives d'aminoindazoles comme inhibiteurs de proteines-kinase
DZ3347A1 (fr)	2001-11-29	Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase
ATE387428T1 (de)	2008-03-15	Chinolinderivate als liganden für den neuropeptid-y-rezeptor
NO20022510L (no)	2002-07-25	Fremgangsmåte for sammenkopling av rör
NO20000940L (no)	2000-08-28	Røroppheng
NO20021962L (no)	2002-04-25	Rörforbindelse
DK1412328T3 (da)	2007-02-12	Dolastatin-10-derivater
ID26948A (id)	2001-02-22	Aditif untuk memperbaiki sifat tahan air dari formulasi kosmetik atau dermatologi
MA26886A1 (fr)	2004-12-20	Acides malonamiques et leurs derives, utiles comme ligands de recepteurs thyroidiens.
EP1272176A4 (fr)	2004-12-29	Derives d'adamantyle utilises comme agents anticancereux
FR2812066B1 (fr)	2003-06-27	Raccord de tuyaux
AU2002215100A1 (en)	2002-05-21	Imidazo-pyrimidine derivatives as ligands for gaba receptors
FR2798367B1 (fr)	2001-11-23	Joint de soupape pour valve doseuse
AU4439801A (en)	2001-10-23	Pyrazolo-triazine derivatives as ligands for gaba receptors
DE69931773D1 (de)	2006-07-20	Rohrverbindung
NO20014455L (no)	2001-09-14	Beleggmateriale for rör
DE50102987D1 (de)	2004-09-02	Gelenkhalterung
NO20015281D0 (no)	2001-10-29	Innretning for forberedede målinger av vann/olje-forhold
MA26947A1 (fr)	2004-12-20	Prodrogues pour ligands recepteurs de nmda
ATE269953T1 (de)	2004-07-15	Rohrverbindung
BR0104265B1 (pt)	2013-11-12	Método de revelação eletrostatográfica